1. Morning Call For April 27, 2015 $HP $DIS $EV $ESS $PRGO $CHRW $SIX $SEAS $MDRX $ROP $LH $AMAT $MRVL $SYMX

  2. LabCorp (LH) Posts Strong Q1 Earnings Post-Covance Buyout $LH $ABC $BDX $NBS http://www.talkmarkets.com/content/stocks--equities/labcorp-lh-posts-strong-q1-earnings-post-covance-buyout?post=63743

  3. $LH: New Insider Transaction on LH by EVP,CEO of LabCorp Diagnostics Boyle James T. Jr.: http://insideri.com/1454748_000112760215015256_0001127602-15-015256

  4. EVP of Laboratory Corporation of America Holdings just disposed of 1,394 shares http://www.conferencecalltranscripts.org/4/summary2/?id=1639008 $LH

  5. Laboratory Corp. (LH) Stock Fell Today After Missing First Quarter Revenue Expectations $LH http://www.thestreet.com/story/13127946/1/laboratory-corp-lh-stock-fell-today-after-missing-first-quarter-revenue-expectations.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  6. $SQNM $ILMN informaseq $LH says pleased with NIPT volume and revenue there+continue to see it as a growth opportunity around women s health.

  7. Laboratory Corp Of America (LH) Earnings Report: Q1 2015 Conference Call Transcript $LH http://www.thestreet.com/story/13127642/1/laboratory-corp-of-america-lh-earnings-report-q1-2015-conference-call-transcript.html?puc=stocktwits&cm_ven=STOCKTWITS&utm_source=dlvr.it&utm_medium=organic&utm_campaign=stocktwits

  8. Revealing justifications put forth concerning $LH latest transcript http://www.conferencecalltranscripts.org/include/?location=http://seekingalpha.com/article/3106146-laboratory-corporation-of-america-holdings-lh-ceo-dave-king-on-q1-2015-results-earnings-call-transcript

  9. Sold $LH calls for a loss, I thought the quarter was great :-/

  10. 10:45AM April 27 Stocks Buzz http://10xtradingsignals.com/2015/04/27/1045am-april-27-stocks-buzz/ $DIS $JD $JRJC $LH

  11. $LH 1Q15 Q&A -Robert, BofA: On restructuring expense? CFO: All deal-related charges were done in 1Q15, only difference is some CIC payments.

  12. $LH 1Q15 Q&A - Robert, BofA: On one-time $30MM?CFO:$30MM would be part of purchase price, would now be treated as cash from operations.

  13. $LH 1Q15 Call-Glenn, CFO: For FY15 we expect EPS $7.55-7.90; operating cash flow $1.045-1.07Bil;CapEx $325-350MM & free cash flow $695-745MM

  14. $LH 1Q15 Call - Glenn, CFO: We expect Lab Corp Diagnostics to grow 3-4% in 2015 after 70BP of negative currency & revenue to grow by 39-42%.

  15. @WSNewsPublishers: 10:45AM Stocks Buzz: http://www.wsnewspublishers.com/1045am-stocks-buzz-the-walt-disney-company-nysedis-jd-com-nasdaqjd-china-finance-online-co-nasdaqjrjc-laboratory-corp-of-america-nyselh/156145/ $DIS $JD $JRJC $LH very

  16. 10:45AM Stocks Buzz: http://www.wsnewspublishers.com/1045am-stocks-buzz-the-walt-disney-company-nysedis-jd-com-nasdaqjd-china-finance-online-co-nasdaqjrjc-laboratory-corp-of-america-nyselh/156145/ $DIS $JD $JRJC $LH

  17. $LH 1Q15 Call -Glenn, CFO: Interest expense $104MM vs. $26MM in 1Q14, due to non-recurring acquisition items of $53MM & higher debt balances

  18. $LH 1Q15 Call - Glenn, CFO: Adjusted operating income was $300MM or 16.9% of revenue compared to $232MM or 16.2% in 1Q14.

  19. $LH 1Q15 Call - Glenn, CFO: SG&A $415MM vs. $285MM in 1Q14. Excluding charges of $87MM of acquisition & Project Launch Pad, SG&A was $328MM.

  20. $LH is in a bullish trend with resistance at $131.19 after releasing earnings this morning.

  21. $LH 1Q15 Call -Glenn, CFO: Gross profit $596MM vs. $517MM in 1Q14, excluding acquisition cost of $33MM, it was $629MM

  22. $LH Earnings result is already out. Check out historical price reaction after ER. http://stocksearning.com/q.aspx?Sys=LH

  23. $LH 1Q15 Call - Glenn, CFO: Covance acquisition contributed $267MM or 19% YoverY; 5% due to strong organic volume in core & esoteric testing

  24. StockTwits Trending Alert: Trading recent interest in LABORATORY CORPORATION $LH http://ideas.quantcha.com/2015/04/27/stocktwits-trending-alert-trading-recent-interest-in-laboratory-corporation-lh/

  25. $LH 1Q15 Call-Dave, CEO: We expect to drive about $300MM in incremental annual revenue by 2018 through accelerated clinical trial enrolments